DIVALGRESS-ER-250

About

Divalgress-ER-250 is an extended-release formulation of divalproex sodium, a medication primarily used in the treatment of epilepsy, bipolar disorder, and migraine prophylaxis. Divalproex sodium works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps to calm excessive electrical activity. It also modulates voltage-gated sodium channels and T-type calcium channels, contributing to its broad spectrum of action.

The extended-release formulation ensures a sustained therapeutic effect, allowing for less frequent dosing and potentially reducing peak-related side effects. This makes Divalgress-ER-250 a valuable option for long-term management of chronic neurological and psychiatric conditions, helping to stabilize mood, prevent seizures, and reduce the frequency and intensity of migraine headaches.

Uses

• Treatment of various seizure types in epilepsy
• Management of manic or mixed episodes in bipolar disorder
• Prophylaxis of migraine headaches
• Adjunctive therapy for certain psychiatric conditions

Directions For Use

Take whole, do not crush or chew, usually once daily with or without food as prescribed by your doctor.

Benefits

• Effective seizure control
• Stabilizes mood in bipolar disorder
• Reduces migraine frequency and severity
• Extended-release for convenient once-daily dosing
• Helps prevent mood swings
• Well-established therapeutic profile

Side Effects

• Nausea, vomiting, or diarrhea
• Abdominal pain
• Drowsiness or sedation
• Tremor
• Hair loss (alopecia)
• Weight gain
• Dizziness
• Headache
• Thrombocytopenia (low platelet count)
• Liver dysfunction
• Pancreatitis
• Polycystic ovary syndrome (PCOS) in women

Safety Measures

• Alcohol - Alcohol can increase the sedative effects of Divalgress-ER and may increase the risk of liver toxicity. Avoid or limit alcohol consumption.
• Pregnancy - Divalgress-ER is associated with a significant risk of birth defects, particularly neural tube defects. It is generally contraindicated in pregnancy, especially in the first trimester, unless benefits outweigh risks.
• Breastfeeding - Divalproex sodium passes into breast milk. Breastfeeding is generally not recommended while taking this medication due to potential infant exposure and adverse effects.
• Liver - Divalgress-ER carries a risk of severe hepatotoxicity, especially in young children and patients with metabolic disorders. Regular liver function monitoring is crucial.
• Kidney - Use with caution in patients with kidney impairment, as dosage adjustments may be necessary. Renal function should be monitored.
• Lung - No specific direct adverse effects on lung function are commonly associated with Divalgress-ER. However, general caution applies to all medications.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.